In vivo activity of anprocide alone, and in vitro activity in combination with conventional antibiotics against Staphylococcus aureus and Staphylococcus epidermidis biofilms

References

1. Barchiesi, F., Schimizzi, A. M., Najvar, L. K., Bocanegra, R., Caselli, F., Di Cesare, S., Giannini, D., Di Francesco, L. F., Giacometti, A. & other authors ( 2001; ). Interactions of posaconazole and flucytosine against Cryptococcus neoformans. Antimicrob Agents Chemother 45, 1355–1359.[CrossRef]
   [Google Scholar]
2. Barchiesi, F., Spreghini, E., Maracci, M., Fothergill, A. W., Baldassarri, I., Rinaldi, M. G. & Scalise, G. ( 2004; ). In vitro activities of voriconazole in combination with three other antifungal agents against Candida albicans. Antimicrob Agents Chemother 48, 3317–3322.[CrossRef]
   [Google Scholar]
3. Donlan, R. M. & Costerton, J. W. ( 2002; ). Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15, 167–193.[CrossRef]
   [Google Scholar]
4. Eliopoulos, G. M. & Moellering, R. C., Jr ( 1996; ). Antimicrobial combinations. In Antibiotics in Laboratory Medicine, 4th edn, pp. 330–396. Edited by V. Lorian. Baltimore, MD: Williams & Wilkins.
5. Gisby, J. & Bryant, J. ( 2000; ). Efficacy of a new cream formulation of mupirocin: comparison with oral and topical agents in experimental skin infections. Antimicrob Agents Chemother 44, 255–260.[CrossRef]
   [Google Scholar]
6. Greco, C., Martincic, I., Gusinjac, A., Kalab, M., Yang, A. F. & Ramírez-Arcos, S. ( 2007; ). Staphylococcus epidermidis forms biofilms under simulated platelet storage conditions. Transfusion 47, 1143–1153.[CrossRef]
   [Google Scholar]
7. Henriques, M., Sousa, C., Lira, M., Elisabete, M., Oliveira, R., Oliveira, R. & Azeredo, J. ( 2005; ). Adhesion of Pseudomonas aeruginosa and Staphylococcus epidermidis to silicone-hydrogel contact lenses. Optom Vis Sci 82, 446–450.[CrossRef]
   [Google Scholar]
8. Klevens, R. M., Morrison, M. A., Nadle, J., Petit, S., Gershman, K., Ray, S., Harrison, L. H., Lynfield, R., Dumyati, G. & other authors ( 2007; ). Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298, 1763–1771.[CrossRef]
   [Google Scholar]
9. Kogan, G., Sadovskaya, I., Chaignon, P., Chokr, A. & Jabbouri, S. ( 2006; ). Biofilms of clinical strains of Staphylococcus that do not contain polysaccharide intercellular adhesin. FEMS Microbiol Lett 255, 11–16.[CrossRef]
   [Google Scholar]
10. Lipsky, B. A., Weigelt, J. A., Gupta, V., Killian, A. & Peng, M. M. ( 2007; ). Skin, soft tissue, bone, and joint infections in hospitalized patients: epidemiology and microbiological, clinical, and economic outcomes. Infect Control Hosp Epidemiol 28, 1290–1298.[CrossRef]
    [Google Scholar]
11. Maki, D. G. ( 1992; ). Infections due to infusion therapy. In Hospital Infections, pp. 849–898. Edited by J. V. Bennett & P. S. Brachman. Boston, MA: Little, Brown & Co.
12. Moreillon, P. & Que, Y. A. ( 2004; ). Infective endocarditis. Lancet 363, 139–149.[CrossRef]
    [Google Scholar]
13. NCCLS ( 2000; ). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that grow Aerobically; Approved Standard M7-A5. Wayne, PA: National Committee for Clinical Laboratory Standards.
14. NNIS System ( 2004; ). National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 32, 470–485.[CrossRef]
    [Google Scholar]
15. Okajima, Y., Kobayakawa, S., Tsuji, A. & Tochikubo, T. ( 2006; ). Biofilm formation by Staphylococcus epidermidis on intraocular lens material. Invest Ophthalmol Vis Sci 47, 2971–2975.[CrossRef]
    [Google Scholar]
16. Pettit, G. R., Smith, R. L. & Klinger, H. ( 1967; ). Synthesis of 3β-acetoxy-17β-(L-arginyl-L-arginyl-L-prolyl)amino-5α-androstane. J Med Chem 10, 145–148.[CrossRef]
    [Google Scholar]
17. Pettit, R. K., Cage, G. D., Pettit, G. R. & Liebman, J. A. ( 2000; ). Antimicrobial and cancer cell growth inhibitory activities of 3β-acetoxy-17β-(l-prolyl)amino-5α-androstane in vitro. Int J Antimicrob Agents 15, 299–304.[CrossRef]
    [Google Scholar]
18. Pettit, R. K., Weber, C. A., Kean, M. J., Hoffmann, H., Pettit, G. R., Tan, R., Franks, K. S. & Horton, M. L. ( 2005; ). Microplate alamar blue assay for Staphylococcus epidermidis biofilm susceptibility testing. Antimicrob Agents Chemother 49, 2612–2617.[CrossRef]
    [Google Scholar]
19. Rohde, H., Burdelski, C., Bartscht, K., Hussain, M., Buck, F., Horstkotte, M. A., Knobloch, J. K. M., Heilmann, C., Herrmann, M. & Mack, D. ( 2005; ). Induction of Staphylococcus epidermidis biofilm formation via proteolytic processing of the accumulation-associated protein by staphylococcal and host proteases. Mol Microbiol 55, 1883–1895.[CrossRef]
    [Google Scholar]
20. Schierholz, J. M. & Beuth, J. ( 2001; ). Implant infections: a haven for opportunistic bacteria. J Hosp Infect 49, 87–93.[CrossRef]
    [Google Scholar]
21. Stamm, W. E. ( 1978; ). Prevention of infections. Infections related to medical devices. Ann Intern Med 89, 764–769.[CrossRef]
    [Google Scholar]
22. Waldvogel, F. A. & Bisno, A. L. ( 2000; ). Infections Associated with Indwelling Medical Devices, 3rd edn. Washington, DC: American Society for Microbiology.
23. Zimmerli, W., Trampuz, A. & Ochsner, P. E. ( 2004; ). Prosthetic-joint infections. N Engl J Med 351, 1645–1654.[CrossRef]
    [Google Scholar]